Diagnostic Value of Immunoglobulin G Anti-Deamidated Gliadin Peptide Antibody for Diagnosis of Pediatric Celiac Disease: A Study from Shiraz, Iran
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Screening serologic tests are important tools for the diagnosis of celiac disease (CD). Immunoglobulin (Ig)G anti-deamidated gliadin peptide (anti-DGP) is a relatively new autoantibody thought to have good diagnostic accuracy, comparable to that of anti-tissue transglutaminase (anti-tTG) antibody. Methods: Pediatric patients (n=86) with a clinical suspicion of CD were included. Duodenal biopsy, anti-tTG, and IgG anti-DGP antibody tests were performed. The patients were divided into CD and control groups based on the pathological evaluation of duodenal biopsies. The diagnostic accuracy of serological tests was determined. Results: IgA anti-tTG and IgG anti-DGP antibodies were positive in 86.3% and 95.4% of patients, respectively. The sensitivity, specificity, and diagnostic accuracy of the IgA anti-tTG test were 86.3%, 50.0%, and 68.6%, respectively, and those of the IgG anti-DGP test were 95.4%, 85.7%, and 90.7%, respectively. The area under the receiver operating characteristic (ROC) curve was 0.84 (95% confidence interval [CI], 0.74–0.91) for IgA anti-tTG test and 0.93 (95% CI, 0.86–0.97) for IgG anti-DGP test. The comparison of IgA anti-tTG and IgG anti-DGP ROC curves showed a higher sensitivity and specificity of the IgG anti-DGP test. Conclusion: IgG anti-DGP is a reliable serological test for CD diagnosis in children. High tTG and DGP titers in the serum are suggestive of severe duodenal atrophy. The combined use of IgA anti-tTG and IgG anti-DGP tests for the initial screening of CD can improve diagnostic sensitivity.
Abstract
Purpose: Screening serologic tests are important tools for the diagnosis of celiac disease (CD). Immunoglobulin (Ig)G anti-deamidated gliadin peptide (anti-DGP) is a relatively new autoantibody thought to have good diagnostic accuracy, comparable to that of anti-tissue transglutaminase (anti-tTG) antibody. Methods: Pediatric patients (n=86) with a clinical suspicion of CD were included. Duodenal biopsy, anti-tTG, and IgG anti-DGP antibody tests were performed. The patients were divided into CD and control groups based on the pathological evaluation of duodenal biopsies. The diagnostic accuracy of serological tests was determined. Results: IgA anti-tTG and IgG anti-DGP antibodies were positive in 86.3% and 95.4% of patients, respectively. The sensitivity, specificity, and diagnostic accuracy of the IgA anti-tTG test were 86.3%, 50.0%, and 68.6%, respectively, and those of the IgG anti-DGP test were 95.4%, 85.7%, and 90.7%, respectively. The area under the receiver operating characteristic (ROC) curve was 0.84 (95% confidence interval [CI], 0.74–0.91) for IgA anti-tTG test and 0.93 (95% CI, 0.86–0.97) for IgG anti-DGP test. The comparison of IgA anti-tTG and IgG anti-DGP ROC curves showed a higher sensitivity and specificity of the IgG anti-DGP test. Conclusion: IgG anti-DGP is a reliable serological test for CD diagnosis in children. High tTG and DGP titers in the serum are suggestive of severe duodenal atrophy. The combined use of IgA anti-tTG and IgG anti-DGP tests for the initial screening of CD can improve diagnostic sensitivity.
참고문헌 (26)
- Guandalini S, "Celiac disease : a review", JAMA Pediatr, 168, pp.272~278 (2014)
- Lebwohl B, "Coeliac disease", Lancet, 391, pp.70~81 (2018)
- Al-Bawardy B, "Celiac disease: a clinical review", Abdom Radiol(NY), 42, pp.351~360 (2017)
- Amarri S, "Antibodies to deamidated gliadin peptides : an accurate predictor of coeliac disease in infancy", J Clin Immunol, 33, pp.1027~1030 (2013)
- Shannahan S, "Diagnosis and updates in celiac disease", Gastrointest Endosc Clin N Am, 27, pp.79~92 (2017)
- Husby S, "AGA clinical practice update on diagnosis and monitoring of celiac disease-changing utility of serology and histologic measures : expert review", Gastroenterology, 156, pp.885~889 (2019)
- Volta U, "Deamidated gliadin peptide antibodies as a routine test for celiac disease : a prospective analysis", J Clin Gastroenterol, 44, pp.186~190 (2010)
- Prause C, "Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease", J Pediatr Gastroenterol Nutr, 49, pp.52~58 (2009)
- Lammi A, "Antibodies to deamidated gliadin peptide in diagnosis of celiac disease in children", J Pediatr Gastroenterol Nutr, 60, pp.626~631 (2015)
- Gould MJ, "In screening for celiac disease, deamidated gliadin rarely predicts disease when tissue transglutaminase is normal", J Pediatr Gastroenterol Nutr, 68, pp.20~25 (2019)
- Mozo L, "Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients", J Pediatr Gastroenterol Nutr, 55, pp.50~55 (2012)
- Dickerson JA, "Deamidated gliadin peptide in pediatric patients with moderately increased tissue transglutaminase; does it help?", Clin Chim Acta, 492, pp.20~22 (2019)
- Olen O, "Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease", J Pediatr Gastroenterol Nutr, 55, pp.695~700 (2012)
- Basso D, "Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children", Clin Chem, 55, pp.150~157 (2009)
- Villalta D, "Testing for IgG class antibodies in celiac disease patients with selective IgA deficiency. A comparison of the diagnostic accuracy of 9 IgG anti-tissue transglutaminase, 1 IgG anti-gliadin and 1 IgG anti-deaminated gliadin peptide antibody assays", Clin Chim Acta, 382, pp.95~99 (2007)
- Ankelo M, "Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease", Clin Exp Immunol, 150, pp.285~293 (2007)
- Sugai E, "Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease", Clin Gastroenterol Hepatol, 4, pp.1112~1117 (2006)
- Bai JC, "The CD that pays dividends : more than 15 years of deamidated gliadin peptide antibodies", Dig Dis Sci, 62, pp.1110~1112 (2017)
- Catassi GN, "Diagnostic accuracy of IgA antitransglutaminase and IgG anti-deamidated gliadin for diagnosis of celiac disease in children under two years of age : a systematic review and meta-analysis", Nutrients, 14, pp.7~ (2021)
- Abdulrahim A, "Deamidated gliadin antibodies: do they add to tissue transglutaminase-IgA assay in screening for celiac disease?", J Pediatr Gastroenterol Nutr, 72, pp.112~118 (2021)
- Oyaert M, "Combining antibody tests and taking into account antibody levels improves serologic diagnosis of celiac disease", Clin Chem Lab Med, 53, pp.1537~1546 (2015)
- Wolf J, "Antibodies in the diagnosis of coeliac disease: a biopsy-controlled, international, multicentre study of 376 children with coeliac disease and 695 controls", PLoS One, 9, pp.e105230~ (2014)
- Vermeersch P, "Diagnostic performance of IgG antideamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease", Clin Chim Acta, 411, pp.931~935 (2010)
- Husby S, "European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020", J Pediatr Gastroenterol Nutr, 70, pp.141~156 (2020)
- Murray JA, "Serologic testing for celiac disease in the United States : results of a multilaboratory comparison study", Clin Diagn Lab Immunol, 7, pp.584~587 (2000)
- Hoerter NA, "Diagnostic yield of isolated deamidated gliadin peptide antibody elevation for celiac disease", Dig Dis Sci, 62, pp.1272~1276 (2017)